News | December 13, 2022
Evonik invests in US based biopharma company ‘Allay Therapeutics’
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The approval further strengthens the Potassium Chloride franchise for the company.
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Therapy recently approved in Canada under the brand name KORSUVA
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Naproxen Sodium Capsules, 220 mg, of Bionpharma
Subscribe To Our Newsletter & Stay Updated
